HLA-DQ association and allele competition in Chinese narcolepsy

Tissue Antigens

Volumn 80, Issue 4, 2012, Pages 328-335

  Han, F ^a   Lin, L ^b   Li, J ^a   Dong, S X ^a   An, P ^a   Zhao, L ^a   Liu, N Y ^a   Li, Q Y ^a   Yan, H ^a   Gao, Z C ^a   Faraco, J ^b   Strohl, K P ^c   Liu, X ^d   Miyadera, H ^e   Mignot, E ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BFR Diagnostics Ltd   (China)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

DQB1*06:02; DRB1*15:01; Human leucocyte antigen; Narcolepsy

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN;

ADOLESCENT; AFRICAN AMERICAN; ALLELE COMPETITION; ARTICLE; CHINA; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE AND NUCLEIC ACID PARAMETERS; HAPLOTYPE; HUMAN; JAPANESE; KOREA; MAJOR CLINICAL STUDY; MALE; NARCOLEPSY; PRIORITY JOURNAL;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE DISEQUILIBRIUM; MALE; NARCOLEPSY; NEUROPEPTIDES; PROTEIN MULTIMERIZATION; YOUNG ADULT;

EID: 84866600513     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2012.01948.x     Document Type: Article

References (51)

1. Silber MH, Krahn LE, Olson EJ, Pankratz VS. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep 2002: 25: 197-202.
2. Kaprio J, Hublin C, Partinen M, Heikkila K, Koskenvuo M. Narcolepsy-like symptoms among adult twins. J Sleep Res 1996: 5: 55-60.
3. Heier MS, Evsiukova T, Wilson J, Abdelnoor M, Hublin C, Ervik S. Prevalence of narcolepsy with cataplexy in Norway. Acta Neurol Scand 2009: 120: 276-80.
4. Shin YK, Yoon IY, Han EK et al. Prevalence of narcolepsy-cataplexy in Korean adolescents. Acta Neurol Scand 2008: 117: 273-8.
5. Longstreth WT Jr, Ton TG, Koepsell T, Gersuk VH, Hendrickson A, Velde S. Prevalence of narcolepsy in King County, Washington, USA. Sleep Med 2009: 10: 422-6.
6. Wing YK, Li RH, Lam CW, Ho CK, Fong SY, Leung T. The prevalence of narcolepsy among Chinese in Hong Kong. Ann Neurol 2002: 51: 578-84.
7. Peyron C, Faraco J, Rogers W et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000: 6: 991-7.
8. Thannickal TC, Moore RY, Nienhuis R et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000: 27: 469-74.
9. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000: 355: 39-40.
10. Mignot E, Lammers GJ, Ripley B et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002: 59: 1553-62.
11. Matsuki K, Juji T, Tokunaga K, Naohara T, Satake M, Honda Y. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics. J Clin Invest 1985: 76: 2078-83.
12. Hong SC, Lin L, Lo B et al. DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans. Hum Immunol 2007: 68: 59-68.
13. Mignot E, Lin L, Rogers W et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001: 68: 686-99.
14. Miyagawa T, Kawashima M, Nishida N et al. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet 2008: 40: 1324-8.
15. Woo HI, Joo EY, Hong SB, Lee KW, Kang ES. Use of PCR with sequence-specific primers for high-resolution human leukocyte antigen typing of patients with narcolepsy. Ann Lab Med. 2012: 32: 57-65.
16. Alaez C, Lin L, Flores AH et al. Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexican patients: a relationship between HLA and gender is suggested. BMC Med Genet 2008: 9: 79.
17. Hor H, Kutalik Z, Dauvilliers Y et al. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 2010: 42: 786-9.
18. Bourgin P, Zeitzer JM, Mignot E. CSF hypocretin-1 assessment in sleep and neurological disorders. Lancet Neurol 2008: 7: 649-62.
19. Kwon OJ, Peled N, Miller K et al. HLA class II analysis in Jewish Israeli narcoleptic patients. Hum Immunol 1995: 44: 199-202.
20. Molari A, Carcassi C. HLA and narcolepsy-cataplexy in the Sardinian population. J Sleep Res 2010: 19: 624-5.
21. Hallmayer J, Faraco J, Lin L et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009: 41: 708-11.
22. Kornum BR, Kawashima M, Faraco J et al. Common variants in P2RY11 are associated with narcolepsy. Nat Genet 2011: 43: 66-71.
23. Han F, Lin L, Li J et al. TCRA, P2RY11, and CPT1B/CHKB associations in Chinese narcolepsy. Sleep Med 2012: 13: 269-72.
24. Shimada M, Miyagawa T, Kawashima M et al. An approach based on a genome-wide association study reveals candidate loci for narcolepsy. Hum Genet 2010: 128: 433-41.
25. Dauvilliers Y, Montplaisir J, Cochen V et al. Post-H1N1 narcolepsy-cataplexy. Sleep 2010: 33: 1428-30.
26. Han F, Lin L, Warby SC et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011: 70: 410-7.
27. Aran A, Lin L, Nevsimalova S et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 2009: 32: 979-83.
28. Partinen M, Saarenpaa-Heikkila O, Ilveskoski I et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 2012: 7: e33723.
29. Mignot E, Kimura A, Lattermann A et al. Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens 1997: 49: 329-41.
30. Rogers AE, Meehan J, Guilleminault C, Grumet FC, Mignot E. HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy. Neurology 1997: 48: 1550-6.
31. Matsuki K, Grumet FC, Lin X et al. DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet 1992: 339: 1052.
32. Neely S, Rosenberg R, Spire JP, Antel J, Arnason BG. HLA antigens in narcolepsy. Neurology 1987: 37: 1858-60.
33. Dalal MA, Schuld A, Pollmacher T. Undetectable CSF level of orexin A (hypocretin-1) in a HLA-DR2 negative patient with narcolepsy-cataplexy. J Sleep Res 2002: 11: 273.
34. Han F, Lin L, Li J et al. Presentations of primary hypersomnia in chinese children. Sleep 2011: 34: 627-32.
35. Pelin Z, Guilleminault C, Risch N, Grumet FC, Mignot E. HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group. Tissue Antigens 1998: 51: 96-100.
36. Weiner Lachmi K, Lin L, Kornum BR et al. DQB1*06:02 allele-specific expression varies by allelic dosage, not narcolepsy status. Hum Immunol 2012: 73: 405-10.
37. Roh EY, Park MH, Park H et al. Association of HLA-DR and -DQ genes with narcolepsy in Koreans: comparison with two control groups, randomly selected subjects and DRB1*1501-DQB1*0602-positive subjects. Hum Immunol 2006: 67: 749-55.
38. Trachtenberg E, Vinson M, Hayes E et al. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. Tissue Antigens 2007: 70: 455-63.
39. Wu Y, Liu B, Lin W et al. Human leukocyte antigen class II alleles and risk of cervical cancer in China. Hum Immunol 2007: 68: 192-200.
40. Romphruk AV, Romphruk A, Kongmaroeng C, Klumkrathok K, Paupairoj C, Leelayuwat C. HLA class I and II alleles and haplotypes in ethnic Northeast Thais. Tissue Antigens 2010: 75: 701-11.
41. Hei AL, Li W, Deng ZH et al. Analysis of high-resolution HLA-A, -B, -Cw, -DRB1, and -DQB1 alleles and haplotypes in 718 Chinese marrow donors based on donor-recipient confirmatory typings. Int J Immunogenet 2009: 36: 275-82.
42. Hohjoh H, Terada N, Honda Y, Juji T, Tokunaga K. Negative association of the HLA-DRB1*1502-DQB1*0601 haplotype with human narcolepsy. Immunogenetics 2001: 52: 299-301.
43. Trejaut J, Bhatia K, Greville WD et al. HLA-DR2 haplotypic diversity in populations of South-East Asia, northern China, Melanesia and Australian aborigines using PCR-RFLP for DRB1, DRB5, DQA1 and DQB1. A novel DRB1 allele: DRB1*16022. EurJ Immunogenet 1996: 23: 437-49.
44. Thomson G, Barcellos LF, Valdes AM. Searching for additional disease loci in a genomic region. Adv Genet 2008: 60: 253-92.
45. Mignot E, Lin L, Li H et al. HLA allele and microsatellite studies in narcolepsy. In: Hansen J, Dupont B, eds. HLA 2004, Immunobiology of the Human MHC, Proceedings of the 13th International Histocompatibility Workshop and Congress. Seattle: IHWG Press, 2006, 817-23.
46. Kwok WW, Kovats S, Thurtle P, Nepom GT. HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation. J Immunol 1993: 150: 2263-72.
47. Sidney J, Steen A, Moore C et al. Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population. J Immunol 2010: 185: 4189-98.
48. Llewelyn M, Sriskandan S, Peakman M et al. HLA class II polymorphisms determine responses to bacterial superantigens. J Immunol 2004: 172: 1719-26.
49. van Lith M, McEwen-Smith RM, Benham AM. HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM. J Biol Chem 2010: 285: 40800-8.
50. Rinderknecht CH, Roh S, Pashine A et al. DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms. Immunology 2010: 131: 18-32.
51. Ridgway WM, Fathman CG. MHC structure and autoimmune T cell repertoire development. Curr Opin Immunol 1999: 11: 638-42.